Works matching IS 1021335X AND DT 2022 AND VI 48 AND IP 2

Results: 12

Expression patterns of uPAR, TF and EGFR and their potential as targets for molecular imaging in oropharyngeal squamous cell carcinoma.

Published in:

Oncology Reports, 2022, v. 48, n. 2, p. N.PAG, doi. 10.3892/or.2022.8359

By:

Christensen, Anders;
Grønhøj, Christian;
Schmidt Jensen, Jakob;
Lelkaitis, Giedrius;
Kiss, Katalin;
Juhl, Karina;
Wittenborg Charabi, Birgitte;
Mortensen, Jann;
Kjær, Andreas;
von Buchwald, Christian

Publication type:

Article

MicroRNA-338 inhibits migration and proliferation by targeting hypoxia-induced factor 1α in nasopharyngeal carcinoma.

Published in:

Oncology Reports, 2022, v. 48, n. 2, p. N.PAG, doi. 10.3892/or.2022.8358

By:

Shan, Ying;
Li, Xingyu;
You, Bo;
Shi, Si;
Zhang, Qicheng;
You, Yiwen

Publication type:

Article

MicroRNA-466 inhibits the aggressive behaviors of hepatocellular carcinoma by directly targeting metadherin.

Published in:

Oncology Reports, 2022, v. 48, n. 2, p. N.PAG, doi. 10.3892/or.2022.8357

By:

Jia, Chen;
Tang, Desheng;
Sun, Chen;
Yao, Lei;
Li, Fujun;
Hu, Yanhua;
Zhang, Xinchen;
Wu, Dequan

Publication type:

Article

Genome-wide expression and methylation analyses reveal aberrant cell adhesion signaling in tyrosine kinase inhibitor-resistant CML cells.

Published in:

Oncology Reports, 2022, v. 48, n. 2, p. N.PAG, doi. 10.3892/or.2022.8355

By:

Kaehler, Meike;
Litterst, Merit;
Kolarova, Julia;
Böhm, Ruwen;
Bruckmueller, Henrike;
Ammerpohl, Ole;
Cascorbi, Ingolf;
Nagel, Inga

Publication type:

Article

SIRT1 suppresses pituitary tumor progression by downregulating PTTG1 expression.

Published in:

Oncology Reports, 2022, v. 48, n. 2, p. N.PAG, doi. 10.3892/or.2022.8354

By:

Huang, Jinxiang;
Zhang, Fenglin;
Hu, Guohan;
Pan, Yuan;
Sun, Wei;
Jiang, Lei;
Wang, Peng;
Qiu, Jiting;
Ding, Xuehua

Publication type:

Article

Alpinia katsumadai Hayata induces growth inhibition and autophagy-related apoptosis by regulating the AMPK and Akt/mTOR/p70S6K signaling pathways in cancer cells.

Published in:

Oncology Reports, 2022, v. 48, n. 2, p. N.PAG, doi. 10.3892/or.2022.8353

By:

An, Weixiao;
Zhang, Yuxi;
Lai, Honglin;
Zhang, Yangyang;
Zhang, Hongmei;
Zhao, Ge;
Liu, Minghua;
Li, Yang;
Lin, Xiukun;
Cao, Shousong

Publication type:

Article

BMI-1 promotes invasion and metastasis in endometrial adenocarcinoma and is a poor prognostic factor.

Published in:

Oncology Reports, 2022, v. 48, n. 2, p. N.PAG, doi. 10.3892/or.2022.8352

By:

Yu, Jing;
Chen, Ling;
Bao, Zhenhua;
Liu, Ying;
Liu, Guohong;
Li, Fengling;
Li, Lon Lianqin

Publication type:

Article

MicroRNA-448 inhibits the progression of retinoblastoma by directly targeting ROCK1 and regulating PI3K/AKT signalling pathway.

Published in:

Oncology Reports, 2022, v. 48, n. 2, p. N.PAG, doi. 10.3892/or.2022.8351

By:

Wu, Shen;
Ai, Nanping;
Liu, Qian;
Zhang, Jingxue

Publication type:

Article

UBE2T regulates FANCI monoubiquitination to promote NSCLC progression by activating EMT.

Published in:

Oncology Reports, 2022, v. 48, n. 2, p. N.PAG, doi. 10.3892/or.2022.8350

By:

Zhang, Jiguang;
Wang, Jingdong;
Wu, Jincheng;
Huang, Jianyuan;
Lin, Zhaoxian;
Lin, Xing

Publication type:

Article

Dual STAT-3 and IL-6R inhibition with stattic and tocilizumab decreases migration, invasion and proliferation of prostate cancer cells by targeting the IL-6/IL-6R/STAT-3 axis.

Published in:

Oncology Reports, 2022, v. 48, n. 2, p. N.PAG

By:

Méndez-Clemente, Anibal;
Bravo-Cuellar, Alejandro;
González-Ochoa, Salvador;
Santiago-Mercado, Maria;
Palafox-Mariscal, Luis;
Jave-Suárez, Luis;
Solorzano-Ibarra, Fabiola;
Villaseñor-García, Maria;
Ortiz-Lazareno, Pablo;
Hernández-Flores, Georgina

Publication type:

Article

Role of 4-aminobutyrate aminotransferase (ABAT) and the lncRNA co-expression network in the development of myelodysplastic syndrome.

Published in:

Oncology Reports, 2022, v. 48, n. 2, p. N.PAG, doi. 10.3892/or.2022.8348

By:

Chen, Yanzhen;
Zhao, Guangjie;
Li, Nianyi;
Luo, Zhongguang;
Wang, Xiaoqin;
Gu, Jingwen

Publication type:

Article

microRNA-485 inhibits the malignant behaviors of retinoblastoma by directly targeting Wnt3a.

Published in:

Oncology Reports, 2022, v. 48, n. 2, p. N.PAG, doi. 10.3892/or.2022.8347

By:

Lyu, Xueman;
Wang, Ling;
Lu, Jia;
Zhang, Hong;
Wang, Lina

Publication type:

Article